Patents by Inventor Murray W. Stewart

Murray W. Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140228288
    Abstract: The present invention provides pharmaceutical compositions comprising at least one polypeptide having GLP-1 activity wherein an effective dose of said pharmaceutical composition comprises 15 mg, 30 mg, 50 mg or 100 mg of said polypeptide having GLP-1 activity. Also provided are methods of administering the pharmaceutical compositions of the invention.
    Type: Application
    Filed: April 25, 2014
    Publication date: August 14, 2014
    Applicant: GlaxoSmithKline, LLC
    Inventors: Mark A. BUSH, Murray W. Stewart, Yonghong Yang
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140228284
    Abstract: The present invention provides pharmaceutical compositions comprising at least one polypeptide having GLP-1 activity wherein an effective dose of said pharmaceutical composition comprises 15 mg, 30 mg, 50 mg or 100 mg of said polypeptide having GLP-1 activity. Also provided are methods of administering the pharmaceutical compositions of the invention.
    Type: Application
    Filed: April 25, 2014
    Publication date: August 14, 2014
    Applicant: GlaxoSmithKline, LLC
    Inventors: Mark A. BUSH, Murray W. Stewart, Yonghong Yang
  • Pharmaceutical compositions
    Patent number: 8748377
    Abstract: The present invention provides pharmaceutical compositions comprising at least one polypeptide having GLP-1 activity wherein an effective dose of said pharmaceutical composition comprises 15 mg, 30 mg, 50 mg or 100 mg of said polypeptide having GLP-1 activity. Also provided are methods of administering the pharmaceutical compositions of the invention.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: June 10, 2014
    Assignee: GlaxoSmithKline LLC
    Inventors: Mark A. Bush, Murray W. Stewart, Yonghong Yang
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20110301080
    Abstract: The present invention provides pharmaceutical compositions comprising at least one polypeptide having GLP-1 activity wherein an effective dose of said pharmaceutical composition comprises 15 mg, 30 mg, 50 mg or 100 mg of said polypeptide having GLP-1 activity. Also provided are methods of administering the pharmaceutical compositions of the invention.
    Type: Application
    Filed: December 10, 2009
    Publication date: December 8, 2011
    Inventors: Mark A. Bush, Murray W. Stewart, Yonghong Yang